Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| CardioVascular Research Foundation, Korea | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Few data are available about the late patency of side branches in association with the currently used stent types and implantation techniques.
Among the bifurcation type, bifurcation lesion without significant side branch stenosis (<50%) usually did not require side branch stenting, but owing to several putative mechanism including dissection, thrombosis formation, embolization of plaque debris, ostial compromise by displaced stent strut, and snow plow effect, the side branch might be compromised. In this situation, the strategy to achieve optimal results has not been reported. Recently, FFR study showed that most jailed side branch (vessel size >2.0 mm. DS>50%) after main branch stenting did not have functional significance. We compared strategies with or without routine kissing balloon dilatation for less than 50% stenosis after simple DES crossing for bifurcation lesions (bifurcation type 1.1.0, 1.0.0, and 0.1.0 according to Medina classification) with serial change of FFR measurement.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| bifurcation stent techniqe | Active Comparator | cross over stenting without kissing balloon angioplasty "leave alone" |
|
| bifurcation stent technique | Experimental | kissing balloon angioplasty |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| kissing balloon | Procedure | simultaneous kissing balloon angioplasty during drug-eluting stent implantation for bifurcation coronary lesions |
|
| Measure | Description | Time Frame |
|---|---|---|
| Diameter stenosis at 8-month follow-up between the kissing balloon inflation and leave alone strategy | 8 month after PCI | 8 months |
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of side branch jail after main vessel stenting according to the stent type used | Day 1 (24 hours after the index procedure) | Day 1 |
| Angiographic reocclusion rate of side branch | 8month after PCI |
Not provided
Inclusion Criteria:
Clinical
Angiographic
Exclusion Criteria:
History of bleeding diathesis or coagulopathy
Pregnant
Known hypersensitivity or contra-indication to contrast agent, heparin, sirolimus, paclitaxel and zotarolimus
Limited life-expectancy (less than 1 year) due to combined serious disease
ST-elevation acute myocardial infarction =< 2 weeks
Characteristics of lesion:
Renal dysfunction, creatinine >= 2.0mg/dL
Contraindication to aspirin, clopidogrel or cilostazol
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Seung-Jung Park, MD, PhD | Asan Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Soonchunhyang University Bucheon Hospital | Bucheon-si | South Korea | ||||
| Busan Saint Mary's Hospital |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| without kissing balloon angioplasty "leave alone" | Procedure | simultaneous kissing balloon angioplasty during drug-eluting stent implantation for bifurcation coronary lesions |
|
|
| 8 months |
| Angiographic restenosis rate of side branch and the main vessel | 8month after PCI | 8 months |
| Late loss of side branch and the main vessel between angiography- and FFR-guided side branch procedure | 8month after PCI | 8 months |
| Angiographic reocclusion, restenosis rate and late loss of the side branch according to the DES type | 8month after PCI | 8 months |
| Angiographic reocclusion, restenosis rate and late loss of the side branch according to bifurcation angle and bifurcation type | 8month after PCI | 8 months |
| Composite of major cardiac adverse events (MACE) including death, MI, stent thrombosis and target vessel revascularization | 2 years |
| FFR of the side branch at post-procedure and at follow-up | Day 1 (immediately after the index procedure)and 8month after PCI | Day 1, 8 months |
| Incidence of peri-procedural cardiac enzyme elevation | Day 1 (24 hours after the index procedure) | Day 1 |
| Fluoroscopic time | Day 1 (immediately after the index procedure) | Day 1 |
| Procedure time | Day 1 (immediately after the index procedure) | Day 1 |
| Amount of contrast agent | Day 1 (immediately after the index procedure) | Day 1 |
| Number of used stents | Day 1 (immediately after the index procedure) | Day 1 |
| Busan |
| South Korea |
| Cheongju Saint Mary's Hospital | Cheongju-si | South Korea |
| Chungnam National University Hospital | Daejeon | South Korea |
| Kyungsang University Hospital | Jinju | South Korea |
| Hallym University Sacred Heart Hospital | Pyeongchon | South Korea |
| Catholic University, Kangnam St. Mary's Hospital | Seoul | South Korea |
| Hallym University Sacred Heart Hospital | Seoul | South Korea |
| Aju University Hospital | Suwon | South Korea |
| Ulsan University Hospital | Ulsan | South Korea |
| Kangwon University Hospital | Wŏnju | South Korea |
| ID | Term |
|---|---|
| D003324 | Coronary Artery Disease |
| ID | Term |
|---|---|
| D003327 | Coronary Disease |
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D001161 | Arteriosclerosis |
| D001157 | Arterial Occlusive Diseases |
| D014652 | Vascular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D020123 | Sirolimus |
| D017239 | Paclitaxel |
| C489443 | zotarolimus |
| ID | Term |
|---|---|
| D018942 | Macrolides |
| D007783 | Lactones |
| D009930 | Organic Chemicals |
| D043823 | Taxoids |
| D043822 | Cyclodecanes |
| D003516 | Cycloparaffins |
| D006840 | Hydrocarbons, Alicyclic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |
| D004224 | Diterpenes |
| D013729 | Terpenes |
Not provided
Not provided